Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials

被引:13
作者
Armendariz, H
Barbieri, MAF
Freigeiro, D
Lastiri, F
Felice, MS
Dibar, E
机构
[1] Hosp Ninos Sor M Ludovica, Serv Hematol, RA-1900 La Plata, Argentina
[2] Hosp Materno Infantil, Serv Oncohematol, San Isidro, Argentina
[3] Hosp Ninos Dr Ricardo Gutierrez, Serv Hematol, Buenos Aires, DF, Argentina
[4] GATLA, Ctr Estasdist, Buenos Aires, DF, Argentina
[5] Hosp Pediat Garrahan, Serv Hematooncol, Buenos Aires, DF, Argentina
[6] Hosp Italiano Buenos Aires, Serv Oncohematol, Buenos Aires, DF, Argentina
关键词
D O I
10.1038/sj.leu.2403854
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2139 / 2142
页数:4
相关论文
共 8 条
[1]   Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party [J].
Chessells, JM ;
Harrison, CJ ;
Kempski, H ;
Webb, DKH ;
Wheatley, K ;
Hann, IM ;
Stevens, RF ;
Harrison, G ;
Gibson, BE .
LEUKEMIA, 2002, 16 (05) :776-784
[2]  
CREUTZIG U, 1985, BLOOD, V65, P298
[3]   Idarubicin improves blast cell clearance during induction therapy in children with AML:: results of study AML-BFM 93 [J].
Creutzig, U ;
Ritter, J ;
Zimmermann, M ;
Hermann, J ;
Gadner, H ;
Sawatzki, DB ;
Niemeyer, CM ;
Schwabe, D ;
Selle, B ;
Boos, J ;
Kühl, J ;
Feldges, A .
LEUKEMIA, 2001, 15 (03) :348-354
[4]   DOES CRANIAL IRRADIATION REDUCE THE RISK FOR BONE-MARROW RELAPSE IN ACUTE MYELOGENOUS LEUKEMIA - UNEXPECTED RESULTS OF THE CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA STUDY BFM-87 [J].
CREUTZIG, U ;
RITTER, J ;
ZIMMERMANN, M ;
SCHELLONG, G .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :279-286
[5]  
FREIGEIRO D, 1989, Sangre (Saragossa), V34, P221
[6]   Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 [J].
Lehrnbecher, T ;
Varwig, D ;
Kaiser, J ;
Reinhardt, D ;
Klingebiel, T ;
Creutzig, U .
LEUKEMIA, 2004, 18 (01) :72-77
[7]  
SACHMANNMURIEL F, 1993, SEMIN ONCOL, V20, P34
[8]   Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial [J].
Webb, DKH ;
Wheatley, K ;
Harrison, G ;
Stevens, RF ;
Hann, IM .
LEUKEMIA, 1999, 13 (01) :25-31